In vitro, downregulation of FGL2 in tumor cells did not affect tumor cell proliferation, but in an experimental glioblastoma mouse model with evidence of DCs with defective differentiation, downregulation of FGL2 impaired tumor progression. This evidence concerns the gene FGL2 and neoplasm.